Answers are grounded in this paper and cite their sources.
RA patients with long-term exposure to TNF-blocking agents were at a greater risk of developing clonal expansions of LGLs. This finding may prompt clinicians to refrain from using these substances in RA patients with known T cell aberrations.
No takes yet. Share an insight, caveat, or question.
Schwaneck et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: